|
⚲
|
| Keyboard |
| Perrin Mark D
✚
|
|
|---|---|
| CIK # | 0001250085 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001250085] | |
| 4 | [0001250085] | |
| 5 | [0001250085] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Perrin Mark D | |
| Invivo Therapeutics Holdings Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Invivo Therapeutics Holdings Corp NVIV
Stock Option(Right to Buy) · derivative
|
2017-01-18 | Grant | 320,000 | $0.00 | |
|
Invivo Therapeutics Holdings Corp NVIV
Common Stock
|
2015-12-31 | Grant | 1,053 | $6.12 | 6,444 |
|
Invivo Therapeutics Holdings Corp NVIV
Stock Option (Right To Buy) · derivative
|
2015-12-10 | Grant | 172,570 | $0.00 | |
|
Invivo Therapeutics Holdings Corp NVIV
Common Stock
|
2014-12-10 | Grant | 57,142 | ||
|
Invivo Therapeutics Holdings Corp NVIV
Stock Option (Right To Buy) · derivative
|
2014-12-10 | Grant | 500,000 | $0.00 | |
|
Invivo Therapeutics Holdings Corp NVIV
STOCK OPTION (RIGHT TO BUY) · derivative
|
2014-01-06 | Grant | 2,000,000 | $0.00 |